89 Beaumont Ave
Given E214
Larner College of Medicine
Burlington, VT 05405
United States
- M.D., St. George's School of Medicine
- M.D., Educational Commission for Foreign Medical Graduates
- B.Sc., Molecular Biology, University of Windsor
Department of Medicine, Division of Hematology and Oncology
Dr. Jasra's UVM Health Network provider page
BIO
Dr. Sakshi Jasra is a physician in the Hematology and Oncology Division at the University of Vermont Medical Center, managing myelodysplastic syndromes and acute leukemias, Non-Hodgkin and Hodgkin Lymphoma, multiple myeloma and myeloproliferative neoplasms. Her work is driven by a clinical interest in clonal hematopoiesis of indeterminate potential, myelodysplastic syndromes and acute leukemias, Non-Hodgkin and Hodgkin Lymphoma.
More importantly, Dr. Jasra’s greatest mission is to care for people at a difficult time in their life, and she feels grateful for this opportunity. She centers her care around treating patients how she would want her own family treated. By making them feel as comfortable as possible during their visits and forming meaningful relationships with each patient, she feels, allows her to provide the best care for her patients.
To further improve her quality of care, her research interests include exploring mechanisms and clinical relevance of clonal hematopoiesis, barriers to improving oncology clinical trial enrollment in rural populations, novel treatment approaches for myelodysplastic syndromes and acute leukemias and the application of cellular therapies in hematologic malignancies.
Dr. Jasra's postdoctoral training
Fellowship in Hematology and Medical Oncology, Montefiore Medical Center, Albert Einstein College of Medicine
Residency in Internal Medicine, University at Buffalo
Dr. Jasra's professional associations
• American Society of Hematology
• American Society of Clinical Oncology
• American College of Physicians
• American Medical Association
Publications
Dr. Jasra's publications on PubMed
Area(s) of expertise
1) Clonal hematopoiesis of indeterminate potential
2) Myelodysplastic Syndromes and Acute Leukemias
3) Non-Hodgkin and Hodgkin Lymphoma
1) Barriers to improving oncology clinical trial enrollment in rural populations
2) Exploring mechanisms and clinical relevance of clonal hematopoiesis
3) Novel treatment approaches for myelodysplastic syndromes and acute leukemias
Bio
Dr. Sakshi Jasra is a physician in the Hematology and Oncology Division at the University of Vermont Medical Center, managing myelodysplastic syndromes and acute leukemias, Non-Hodgkin and Hodgkin Lymphoma, multiple myeloma and myeloproliferative neoplasms. Her work is driven by a clinical interest in clonal hematopoiesis of indeterminate potential, myelodysplastic syndromes and acute leukemias, Non-Hodgkin and Hodgkin Lymphoma.
More importantly, Dr. Jasra’s greatest mission is to care for people at a difficult time in their life, and she feels grateful for this opportunity. She centers her care around treating patients how she would want her own family treated. By making them feel as comfortable as possible during their visits and forming meaningful relationships with each patient, she feels, allows her to provide the best care for her patients.
To further improve her quality of care, her research interests include exploring mechanisms and clinical relevance of clonal hematopoiesis, barriers to improving oncology clinical trial enrollment in rural populations, novel treatment approaches for myelodysplastic syndromes and acute leukemias and the application of cellular therapies in hematologic malignancies.
Dr. Jasra's postdoctoral training
Fellowship in Hematology and Medical Oncology, Montefiore Medical Center, Albert Einstein College of Medicine
Residency in Internal Medicine, University at Buffalo
Dr. Jasra's professional associations
• American Society of Hematology
• American Society of Clinical Oncology
• American College of Physicians
• American Medical Association
Publications
Areas of Expertise
1) Clonal hematopoiesis of indeterminate potential
2) Myelodysplastic Syndromes and Acute Leukemias
3) Non-Hodgkin and Hodgkin Lymphoma
1) Barriers to improving oncology clinical trial enrollment in rural populations
2) Exploring mechanisms and clinical relevance of clonal hematopoiesis
3) Novel treatment approaches for myelodysplastic syndromes and acute leukemias